Abiopharma

Avidity Biosciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avidity Biosciences, Inc. - RNA

X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million

Incyte maakt nieuwe gegevens bekend uit fase 3b TRuE-AD4-onderzoek naar Opzelura® (ruxolitinibcrème) bij volwasssen met matige atopische dermatitis

NRC Health Announces Third Quarter 2025 Results

Amwell® to report third quarter 2025 operating results; company leaders to attend upcoming investor conferences

AngioDynamics to Participate in the UBS Global Healthcare Conference

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025

Agilent Names Adam S. Elinoff as Chief Financial Officer

Dexcom Appoints Euan Ashley to Board of Directors